“Enhanced Precision Through AI and Automation Integration”
- A significant and accelerating trend in the global veterinary antimicrobial susceptibility testing (AST) market is the growing integration of artificial intelligence (AI) and automation technologies into diagnostic platforms, significantly improving the precision, speed, and efficiency of AST procedures
- For instance, companies are developing AI-driven platforms that automate sample analysis and result interpretation, reducing manual errors and enhancing consistency across tests. Systems such as Becton, Dickinson and Company’s Phoenix™ M50 integrate AI to optimize antimicrobial panel testing and deliver faster, more accurate susceptibility results
- AI integration in veterinary AST enables predictive analytics for resistance trends, aiding in epidemiological surveillance and antibiotic stewardship. Automated systems can flag unusual resistance patterns, suggest tailored treatment options, and generate alerts for emerging AMR threats, supporting timely interventions by veterinarians
- The seamless integration of AST platforms with digital veterinary health records and laboratory information systems ensures centralized management of data, enabling faster clinical decisions and better monitoring of antimicrobial usage across animal populations
- This trend toward more intelligent, automated, and data-integrated AST workflows is reshaping expectations for veterinary diagnostics, prompting companies such as BioMérieux and Thermo Fisher Scientific to invest in AI-enhanced AST tools that provide both high-throughput and highly accurate resistance profiling
- The demand for smart veterinary AST systems is growing rapidly across both livestock and companion animal segments, as stakeholders prioritize speed, reliability, and evidence-based treatment decisions to combat rising antimicrobial resistance globally
